Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition
Yuichi Suzuki(Hokkaido University), Hideyoshi Harashima(Hokkaido University), Haruno Onuma(Hokkaido University), Michinori Kohara(Tokyo Metropolitan Institute of Medical Science), Akari Hashiba(Hokkaido University), Yusuke Sato(Kyoto University), Masatoshi Maeki(Japan Science and Technology Agency), Mohammad Enamul Hoque Kayesh(Kagoshima University), Kyoko Tsukiyama–Kohara(Kumamoto University), Risa Sato(Hokkaido University), Manabu Tokeshi(Hokkaido University)
Cited by 97
Related Papers
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
|Biological and Pharmaceutical Bulletin|2013|479
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
|Blood|2017|352
Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases
|Advanced Drug Delivery Reviews|2008|254
Sustainable Antibiotic-Free Broiler Meat Production: Current Trends, Challenges, and Possibilities in a Developing Country Perspective
|Biology|2020|141
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
|Advanced Drug Delivery Reviews|2020|123